Prediction of tablet hardness and porosity using near-infrared diffuse reflectance spectroscopy as a nondestructive method

被引:61
作者
Donoso, M
Kildsig, DO
Ghaly, ES
机构
[1] Univ Puerto Rico, Sch Pharm, San Juan, PR 00936 USA
[2] Purdue Univ, Sch Pharm & Pharmacial Sci, W Lafayette, IN 47907 USA
基金
美国国家科学基金会;
关键词
near-infrared spectroscopy; hardness; porosity; theophylline; NIR; diffuse reflectance spectroscopy; prediction; validation;
D O I
10.1081/PDT-120024689
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The main objective of this research is to use the near-infrared diffuse reflectance method to evaluate and quantify the effects of hardness and porosity on the near-infrared spectras of tablets. To develop a model equation, validate the model and test the model predictive ability. Seven theophylline tablet formulations of the same composition but with seven different hardness values (3, 6, 8, 10, 12, 15, and 17 kp) were prepared. Another seven theophylline tablets formulation with seven different porosity values (57.4, 50.3, 41.9, 40.3, 39.9, 37.3, and 35.1%) were prepared. Five placebo tablets formulation with different hardness and porosity values were also prepared. Laboratory hardness and porosity values were compared to near-infrared diffuse reflectance data. Linear regression, quadratic, cubic and partial least square techniques were used to determine the relationship between hardness, porosity and the near-infrared spectras. The results demonstrated that an increase in tablet hardness and a decrease in tablets porosity produced an increase in near-infrared absorbance. Series of model equations depending on the mathematical technique used for regression were developed from the calibration of hardness and porosity data using laboratory equipment vs. the near-infrared diffuse reflectance for each formulations. The results of near-infrared hardness and porosity predictions were very similar to laboratory hardness and porosity tests. The near-infrared diffuse reflectance spectroscopy method is an alternative nondestructive method for measurement of hardness and porosity of tablets.
引用
收藏
页码:357 / 366
页数:10
相关论文
共 10 条
[1]
Quantitative analysis of film coating in a fluidized bed process by in line NIR spectrometry and multivariate batch calibration [J].
Andersson, M ;
Folestad, S ;
Gottfries, J ;
Johansson, MO ;
Josefson, M ;
Wahlund, KG .
ANALYTICAL CHEMISTRY, 2000, 72 (09) :2099-2108
[2]
BALNCO M, 1999, J PHARM SCI, V88, P551
[3]
Development and validation of a method for the analysis of a pharmaceutical preparation by near-infrared diffuse reflectance spectroscopy [J].
Blanco, M ;
Coello, J ;
Eustaquio, A ;
Iturriaga, H ;
Maspoch, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (05) :551-556
[4]
Strategies for constructing the calibration set in the determination of active principles in pharmaceuticals by near infrared diffuse reflectance spectrometry [J].
Blanco, M ;
Coello, J ;
Iturriaga, H ;
Maspoch, S ;
delaPezuela, C .
ANALYST, 1997, 122 (08) :761-765
[5]
Application of transmission near-infrared spectroscopy to uniformity of content testing of intact steroid tablets [J].
Broad, NW ;
Jee, RD ;
Moffat, AC ;
Smith, MR .
ANALYST, 2001, 126 (12) :2207-2211
[6]
Prediction of drug content and hardness of intact tablets using artificial neural network and near-infrared spectroscopy [J].
Chen, YX ;
Thosar, SS ;
Forbess, RA ;
Kemper, MS ;
Rubinovitz, RL ;
Shukla, AJ .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (07) :623-631
[7]
Application of near-infrared spectroscopy in the pharmaceutical solid dosage form [J].
Guo, JH ;
Skinner, GW ;
Harcum, WW ;
Malone, JP ;
Weyer, LG .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (12) :1267-1270
[8]
Qualitative determination of polyvinylpyrrolidone type by near-infrared spectrometry [J].
Kreft, K ;
Kozamernik, B ;
Urleb, U .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 177 (01) :1-6
[9]
Near-infrared spectroscopy as a nondestructive alternative to conventional tablet hardness testing [J].
Morisseau, KM ;
Rhodes, CT .
PHARMACEUTICAL RESEARCH, 1997, 14 (01) :108-111
[10]
SEVER JJ, 2000, J PHARM SCI, V89, P1305